Annica Holdings Limited (SGX:5AL)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21	19	17	17	17	17
Market Cap Growth	23.87%	13.46%	-	1.80%	-	-
Enterprise Value	22	19	18	17	17	16
Last Close Price	0.00	0.00	0.00	0.00	0.00	0.00
PS Ratio	1.75	1.53	1.07	1.13	2.18	1.53
PB Ratio	5.35	9.11	-34.50	29.17	8.28	5.18
P/TBV Ratio	5.63	11.13	-	28.34	8.28	5.24
P/FCF Ratio	-	-	12.68	17.34	-	-
P/OCF Ratio	568.30	-	12.05	15.56	-	104.87
EV/Sales Ratio	1.81	1.48	1.16	1.16	2.23	1.44
EV/FCF Ratio	-62.07	-	13.75	17.75	-	-
Debt / Equity Ratio	0.54	1.05	-5.49	2.52	0.86	0.63
Debt / EBITDA Ratio	-	61.72	-	-	-	-
Debt / FCF Ratio	-	-	2.02	1.50	-	-
Asset Turnover	0.99	1.12	1.18	1.23	0.77	1.10
Inventory Turnover	4.79	9.85	30.27	28.14	9.50	18.27
Quick Ratio	0.46	0.43	0.50	0.38	0.52	0.78
Current Ratio	0.61	0.72	0.93	1.05	1.35	1.64
Return on Equity (ROE)	18.39%	34.75%	-1586.67%	-133.13%	-43.08%	-31.55%
Return on Assets (ROA)	-2.91%	-2.43%	-3.51%	-9.37%	-9.79%	-10.40%
Return on Capital (ROIC)	-10.26%	-8.34%	-22.17%	-39.35%	-21.66%	-19.79%
Earnings Yield	1.72%	-0.11%	-7.28%	-8.81%	-6.57%	-6.81%
FCF Yield	-1.67%	-2.51%	7.89%	5.77%	-1.47%	-2.06%
Buyback Yield / Dilution	-10.98%	-4.30%	-1.13%	-0.66%	-	-0.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.